Malignant peripheral nerve sheath tumor epidemiology and demographics

Malignant peripheral nerve sheath tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X-Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Malignant peripheral nerve sheath tumor epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Malignant peripheral nerve sheath tumor epidemiology and demographics
CDC on Malignant peripheral nerve sheath tumor epidemiology and demographics
Malignant peripheral nerve sheath tumor epidemiology and demographics in the news
Blogs on Malignant peripheral nerve sheath tumor epidemiology and demographics
Directions to Hospitals Treating Malignant peripheral nerve sheath tumor
Risk calculators and risk factors for Malignant peripheral nerve sheath tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Malignant peripheral nerve sheath tumors comprise ∼2% of all sarcomas whichare a small fraction of a group of cancers that affect 5 people per million per year. The incidence of malignant peripheral nerve sheath tumor is approximately 0.1 per 100,000 individuals worldwide. The incidence of malignant peripheral nerve sheath tumor increases with age. Malignant peripheral nerve sheath tumor affects men and women equally.

Incidence

• Malignant peripheral nerve sheath tumors comprise ∼2% of all sarcomas whichare a small fraction of a group of cancers that affect 5 people per million per year.
• The incidence of malignant peripheral nerve sheath tumor is approximately 0.1 per 100,000 individuals worldwide.
• Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection.
• Half of MPNSTs are associated with neurofibromatosis type 1 (NF1), the autosomal dominant condition that, affecting 1 in 3000 live births, represents the most common human cancer genetic predisposition syndrome.

Age

• Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally .

Gender

• Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally.